Skip to main content

Market Overview

58 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • Immuron Limited (NASDAQ: IMRN) shares jumped 159% to $16.50 after guidance from the FDA cleared the way for two clinical studies in 2021 and will help the company with development of an investigational new drug application.
  • DPW Holdings Inc (NYSE: DPW) shares surged 129.1% to $4.72 after the company reported it has released a product line of electric vehicle charges.
  • Just Energy Group Inc. (NYSE: JE) shares jumped 87.7% to $0.6649 after the company received an interim order from the Ontario Superior Court of Justice which grants a stay of proceedings for the company's recapitalization plan.
  • Majesco (NASDAQ: MJCO) gained 69% to $12.92 after the company agreed to be acquired by Thoma Bravo for $13.10 per share.
  • Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares surged 47% to $3.253.
  • iBio, Inc. (NYSE: IBIO) shares climbed 37.7% to $5.38 after the company’s stock climbed almost 100% last week.
  • Borqs Technologies Inc (NASDAQ: BRQS) climbed 37.7% to $1.17 after the company said it expects delivery of 250,000 units in the fiscal year ending December 31, 2020.
  • Forum Energy Technologies, Inc. (NYSE: FET) shares gained 33.8% to $0.5650. Forum Energy Technologies last week said it projects preliminary Q2 sales of $110 million to $115 million.
  • Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) gained 28% to $2.86.
  • PDS Biotechnology Corporation (NASDAQ: PDSB) rose 27.2% to $3.813.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) rose 27.2% to $1.03 in pre-market trading after jumping 27% in the previous session. On Thursday, Tonix Pharmaceuticals reported a research collaboration to develop precision medicine techniques for coronavirus vaccines and therapeutics.
  • Priority Technology Holdings, Inc. (NASDAQ: PRTH) gained 25% to $2.74.
  • AIM ImmunoTech Inc. (NYSE: AIM) surged 23% to $3.755.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) rose 21.4% to $0.9881 following a 20% surge on Friday.
  • Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) rose 20.7% to $2.68 after gaining over 9% on Friday. Idera Pharmaceuticals last week announced a private placement of up to $20 million.
  • Daqo New Energy Corp. (NYSE: DQ) rose 20.6% to $106.98.
  • BioXcel Therapeutics Inc (NASDAQ: BTAI) jumped 20.4% to $63.79 as the company disclosed that BXCL501 met the primary and secondary endpoints in two pivotal Phase 3 trials.
  • AIkido Pharma Inc. (NASDAQ: AIKI) rose 20% to $1.2350 after climbing about 10% on Friday.
  • Capricor Therapeutics, Inc. (NASDAQ: CAPR) gained 19.2% to $6.34.
  • Lion Financial Group Limited (NASDAQ: LGHL) surged 18.4% to $5.60.
  • Heat Biologics, Inc. (NASDAQ: HTBX) rose 18.3% to $2.9095 after climbing 25% on Friday.
  • IMV Inc. (NASDAQ: IMV) gained 17% to $5.88. IMV appointed Michael P. Bailey to its Board of Directors.
  • Sorrento Therapeutics Inc (NASDAQ: SRNE) surged 16.8% to $8.14 after the company disclosed that it has received the FDA clearance to initiate a Phase 2 trial of Abivertinib in patients with Covid-19 who have moderate to severe pulmonary symptoms.
  • Denbury Resources Inc. (NYSE: DNR) shares gained 16.7% to $0.2654 following a report suggesting the company is evaluating an acquisition proposal at $1.20 per share.
  • GlobalSCAPE, Inc. (NYSE: GSB) rose 16.6% to $9.55. GlobalSCAPE and HelpSystems signed a merger agreement.
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) gained 16.5% to $3.88 after the company reported preclinical results from initial efficacy study exploring combination of granulocyte-macrophage colony-stimulating factor with interleukins 18 and 12.
  • Novan, Inc. (NASDAQ: NOVN) rose 15% to $0.7069.
  • 360 Finance, Inc. (NASDAQ: QFIN) shares gained 15% to $17.37 after peer Chinese fintech company, Ant Financial, filed for an IPO.
  • Ceragon Networks Ltd. (NASDAQ: CRNT) rose 12.8% to $2.73.
  • ContraFect Corporation (NASDAQ: CFRX) surged 12.2% to $6.88 after the company reported up to $18.9m in funding from CARB-X to support acceleration of CF-370 program for treating pseudomonas aeruginosa infections towards clinical stage development.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) rose 11% to $0.6859 after climbing around 19% on Friday.
  • Up Fintech Holding Ltd (NASDAQ: TIGR) gained 11% to $5.90 after Alibaba announced the IPO of its Ant Financial group. UP Fintech is a peer financial services company to Ant Financial in China.
  • Rosetta Stone Inc (NYSE: RST) gained 10% to $22.00 following Friday reports that the company hired an advisor to explore the sale of the company.
  • Assembly Biosciences Inc (NASDAQ: ASMB) gained 8.5% to $26.57 after the company disclosed that it has granted BeiGene rights to develop and commercialize its clinical-stage inhibitors for Hepatitis B in China.
  • Northern Dynasty Minerals Ltd. (NYSE: NAK) rose 7.1% to $1.81 after gaining around 13% on Friday. Northern Dynasty last week announced closing of $35.3 million bought deal.
  • Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) climbed 6.5% to $3.50 after the company said its Caldolor demonstrated a significant reduction of opioid use in orthopedic trauma patients.
  • Churchill Capital Corp II (NYSE: CCX) rose 5.5% to $11.61 after Bloomberg reported that Topgolf is in talks to go public via Churchill Capital Corp. II.
  • Quotient Limited (NASDAQ: QTNT) rose 5.3% to $8.73 after the company reported results from an independent SARS-CoV-2 antibody detection study conducted in Spain.
  • Noble Energy, Inc. (NASDAQ: NBL) rose 5.3% to $10.16 after the company agreed to be acquired by Chevron Corporation (NYSE: CVX) for $10.38 per share.
  • Koninklijke Philips NV (NYSE: PHG) gained 5.1% to $52.29 after the company reported upbeat Q2 results.
  • Eros International plc (NYSE: EROS) rose 5% to $3.46 after the company announced its app would be pre-installed on select Sony smart TVs in India.
  • BioNTech SE – ADR (NASDAQ: BNTX) rose 4.8% to $89.21. Pfizer Inc (NYSE: PFE) and BioNTech reported an agreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2.

Check out these big penny stock gainers and losers

Losers

  • Genetic Technologies Limited (NASDAQ: GENE) shares tumbled 26.8% to $4.15. On Thursday, Genetic Technologies priced a 1.025 million ADS offering at $5 per ADS.
  • CBL & Associates Properties, Inc. (NYSE: CBL) shares dropped 23.7% to $0.1871 following an 11% decline on Friday.
  • Nikola Corporation (NASDAQ: NKLA) fell 19.3% to $39.43 after the company disclosed a common stock offering.
  • Color Star Technology Co Ltd (NASDAQ: HHT) fell 19% to $1.41 after the company announced a $4.2 million common stock offering.
  • PetMed Express, Inc. (NASDAQ: PETS) dropped 16% to $34.03 after reporting earnings for the first quarter.
  • Houghton Mifflin Harcourt Company (NASDAQ: HMHC) fell 15.2% to $2.3750 after gaining 19% on Friday. On Friday, Houghton Mifflin Harcourt responded to 'false rumors' on Twitter regarding new sales contracts.
  • WiMi Hologram Cloud Inc. (NASDAQ: WIMI) fell 13.4% to $14.11.
  • Verona Pharma plc (NASDAQ: VRNA) fell 12.8% to $8.89. Verona Pharma shares climbed 112% on Friday after the company announced it raised $200 million in a private placement at $4.50 per share.
  • Barnes & Noble Education, Inc. (NYSE: BNED) dropped 12% to $2.21.
  • Ashford Hospitality Trust, Inc. (NYSE: AHT) declined 11.5% to $6.13
  • Boxlight Corporation (NASDAQ: BOXL) fell 11.2% to $3.26 after declining around 13% on Friday. Boxlight’s website discussed collaboration with Samsung last week.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) shares declined 10.6% to $4.9099. On Friday, PhaseBio announced it dosed the first patient in VANGUARD, a Phase 2 clinical trial evaluating PB1046 as a treatment for Covid-19 patients.
  • MicroVision, Inc. (NASDAQ: MVIS) dropped 10.5% to $2.4250.
  • Moderna Inc (NASDAQ: MRNA) fell 10.3% to $85.11 after a paper surfaced that allegedly showed Pfizer & BioNtech's vaccine candidate, BNT162b1, gives a stronger T-cell response than Moderna's vaccine candidate.
  • AC Immune SA (NASDAQ: ACIU) dropped 9.4% to $7.50. AC Immune last week announced it has advanced its phospho-tau Alzheimer's vaccine in its phase 1b/2a study.
  • RumbleON, Inc. (NASDAQ: RMBL) fell 7.7% to $23.69. RumbleON shares surged over 139% on Friday after the company announced a dealer-centric pilot program with CarGurus.
 

Related Articles (ACRS + ACIU)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Penny Stocks Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com